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A B S T R A C T
A 47-year-old man was admitted to the hospital with a pleuritic pain, dyspnea, nonproductive cough and low-grade
fever. An ECG documented a sinus tachycardia with S1Q3T3 pattern and incomplete right bundle branch block, and lung
scintigraphy showed multiple perfusion defects. The initial diagnosis was pulmonary embolism. Echocardiography, un-
dertaken before application of the anticoagulant therapy because of hematological disturbances reflecting possible coagu-
lopathy (elevated erythrocyte sedimentation rate, increased leukocyte count, decreased platelet count), revealed a large
mobile tumor in the right atrium. Tumor was surgically removed, and histological findings was supported a diagnosis
of the cardiac myxoma. The right cardiac myxoma should be considered in the differential diagnosis of pulmonary embo-
lism, particularly in cases presented in conjunction with constitutional symptoms and/or hematological disturbances. In
these patients echocardiography should be undertaken early to exclude the rare but treatable diseases of the right heart.
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Introduction
Myxoma is the most common cardiac tumor1,2. De-
spite its benign pathologic nature, catastrophic results
can occur because of systemic or pulmonary embolism
and/or intracardiac obstruction1–3. In some cases myxo-
ma can be accompanied with nonspecific extracardiac
symptoms and hematological disturbances that fail to
suggest the proper etiology4,5. We report a case of pulmo-
nary embolism and hematological disorder secondary to
a large right atrial myxoma.
Case Report
A 47-year-old man was admitted to our hospital with
a right-sided pleuritic chest pain, dyspnea, nonproduc-
tive cough and low-grade fever. Dyspnea and nonproduc-
tive cough had appeared 8 months previously but the se-
verity and frequency of symptoms worsened in the pre-
vious 2 weeks, especially in exertion and supine position.
In addition to these symptoms he has become weak and
easily fatigued. He has no conventional cardiovascular
risk factors.
On physical examination patient was feverish (37.6
°C) and tachypnoic (a respiratory rate of 28/min). There
was no jugular venous distention. Peripheral pulse exam-
ination revealed normal carotid and extremity arterial
pulsation. His arterial pressure was 140/85 mmHg, and
pulse 110 beats per minute. Cardiac auscultation re-
vealed regular rhythm, and no murmurs or extra heart
sounds. Lungs were clear to auscultation. There was no
lower extremity edema or evidence of peripheral venous
thrombosis.
An ECG documented a sinus tachycardia (110/min)
with S1Q3T3 pattern, and incomplete right bundle branch
block. Chest radiography demonstrated mild cardiome-
galy. Radionuclide lung perfusion scan showed multiple
moderately sized segmental and subsegmental defects in
both lungs. The patients erythrocyte sedimentation rate
(47 mm/h), total leukocyte count (16.700/ mm3), C-reac-
tive protein (32.5 mg/L), D-dimers (1375 (g/L), and se-
rum lactate dehydrogenase level (1478 U/L) were increa-
sed, while platelet count (83.000/mm3) was decreased.
Other hematological and biochemical parameters were in
the normal limits. In blood gas analysis there were only
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slightly decreased pO2 (8.4 kPa) and O2 saturation (93%).
Antinuclear and anticardiolipin antibodies were nega-
tive, and no lupus anticoagulant was detected.
The initial diagnosis was pulmonary embolism. Be-
cause of the decreased platelet count and possibility of an
underlying coagulopathy, patient was not treated with
anticoagulant therapy. Also, patient’s medical history
and laboratory findings suggested possibility of cardiac
myxoma. Therefore, patient was referred to echocardio-
graphy.
Transthoracic echocardiography (TTE) using Vivid 3,
General Electric, Milwaukee, WI, USA, machine demon-
strated normal left ventricular size and function, normal
left atrial size, and normal function of the aortic and mi-
tral valves. The right atrium (RA=56 mm) and right ven-
tricle (RV=45 mm) were enlarged. A large mobile mass
was identified in the right atrium. There is no pericardial
effusion. Transesophageal echocardiography (TEE) us-
ing a 5-MHz multiplane imaging transducer revealed a
tumors mass in the right atrium, attached with a stalk
close to the entry of the inferior vena cava. The tumor ex-
tended during diastole through the tricuspid valve into
the right ventricle almost to the right ventricular apex
causing severe relative tricuspid valve stenosis (Figure
1). Also, a moderate tricuspid regurgitation (angiogra-
phic grade +2/+3) was registered by color Doppler. Right
ventricular systolic pressure estimated from tricuspid
regurgitant jet (RVSP=45 mmHg), as well as shorter
pulmonary valve acceleration time (PVaccT = 89 ms),
suggested moderate pulmonary hypertension.
Immediate surgical treatment was indicated because
of the high risk of recurrent, potentially fatal, embolism.
The surgeon completely removed a tumor with the sur-
rounding endocardium. Macroscopically, the resected tu-
mor was a well-defined encapsulated mass with a smooth
contour weighted 129 g and measured 98 x 56 x 44 mm in
size (Figure 2). Hystologically, the tumor consisted of a
hypocellular mass of a myxoid matrix, rich in acid muco-
polysaccharides, with a supporting structure of spindle-
like, elongated or stellate cells scattered in an abundant
stroma. These findings supported diagnosis of myxoma.
Excision of the tumor resulted in marked symptom-
atic and hematological improvement. The patient was
discharged 10 days after the operation. Six months later
the patient was asymptomatic. Follow-up echocardio-
graphy showed normal cavities dimensions and ventricu-
lar function. However, mild to moderate tricuspid regur-
gitation (angiographic grade +1/+2) was still evident.
Also, there was a slightly elevated pulmonary artery
pressure (RVSP=33 mmHg, PVaccT 106 ms). One year
later, the patient remains well, with normal echocardio-
graphic finding and pulmonary artery pressure.
Discussion
Primary cardiac tumors are uncommon with the inci-
dence between 0.0017 % and 0.33%1,2. About two-thirds
of these tumors are myxoma that typically arises in the
left atrium (80%) along the interatrial septum near the
fossa ovalis. Occasionally, myxomas arise in the right
atrium (15%), the ventricles (3–4%), or valves. Rarely,
the tumor is present in more than one cavity1,2. Cardiac
myxomas arise more frequently in women and usually
present between the ages of 50 and 70 years1,2. Sporadic
cases of myxoma are almost always single. However, ap-
proximately 7% of cardiac myxomas are a component of a
complex hereditary syndrome that affects multiple or-
gans1.
Clinical manifestations of cardiac myxomas are most
often determined by tumor size, location and mobility,
and can be separated into three sessions: (1) symptoms of
mechanical valvular obstruction, (2) embolization to the
pulmonary or systemic circulation and (3) nonspecific
constitutional symptoms and/or hematological findings1–5.
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Fig. 1. Midesophageal four-chamber echocardiographic study in (a) systole and (b) diastole, revealing a right atrial (RA) mass (M) with
a stalk (arrow) extended through the tricuspide valve into the right ventricle (RV). LA denotes left atrium, LV – left ventricle.
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Obstruction to blood flow may occur at the orifice of
any valve mimicking the clinical picture of valve stenosis.
If the tumor is large enough, soft and easily deformable,
and if it has a long stalk, temporary complete valve ob-
struction may occur, resulting in syncope or sudden
death. However, the most frequently obstructive symp-
tom is dyspnea that occurs in approximately 80% of pa-
tients with atrial myxoma1,2. Left atrial myxoma pro-
duces symptoms when it reaches approximately 7 cm in
size. Those in the right atrium that produce symptoms
are usually approximately twice as large and sometimes
several-fold larger6.
Embolic phenomenon in cardiac myxoma is common,
with the incidence ranging from 30% to 40%1,2. In left-
sided cardiac myxomas the emboli generally display a
predilection for the central nervous system, but also can
affect other organs such as the liver, spleen, kidney, ret-
ina, coronary vessels, abdominal aorta, and distal arte-
rial tree1,2,5,7. In right-sided myxomas, clinically evident
embolism is uncommon. Nevertheless, in these cases,
there have been reports not only of repeated mycroembo-
lization into the pulmonary vessels with subsequent pul-
monary hypertension, but also of lethal pulmonary em-
bolism3. The myxoma size is a significant determinant of
valvular obstruction and constitutional symptoms, whe-
reas the villous or papillary type and irregular surface is
a risk factor for embolism4,5. Also, males are statistically
at greater risk than females of developing embolic com-
plications4,5. Our case is unusual because a large solid
myxoma with a smooth surface cause pulmonary embo-
lization.
Constitutional symptoms (fever, weight loss, weak-
ness, fatigue, Raynaud's phenomenon, erythematous
rash, digital clubbing, arthralgias) and laboratory find-
ings (anemia, elevated erythrocyte sedimentation rate,
elevated leukocyte count, decreased platelet count, posi-
tive seroreactive protein, and abnormal serum proteins)
are reported in 10–45% of patients1,2,5,6. These symptoms
may mimic infective endocarditis, collagen vascular dis-
ease, or occult malignancy, and may be due to the release
of the acute phase reactant interleukin-6 from the tumor
leading to inflammatory and autoimmune manifesta-
tions5. Plasma interleukin-6 concentration correlated po-
sitively with both the myxoma size and constitutional
symptoms4,5. Although nonspecific constitutional symp-
toms and laboratory findings are most often in patients
with left atrial myxoma4, our case serves to remind the
clinician that these symptoms can also be found in pa-
tients with a right-sided myxoma.
Cardiac myxomas range from small (< 1 cm or < 10 g)
to large (> 10 cm or > 100 g) 1,5. Lazarides was reported a
right atrial myxoma that weighed 450 g6! However, how
fast atrial myxomas grow has never been clarified. It was
estimated that recurrent atrial myxomas grow an aver-
age of 0.24–1.6 cm per year1. Therefore, the large tumors
size in our patient assumed that this intracardiac pathol-
ogy existed for some years prior to diagnosis.
Before the introduction of echocardiography, the time
interval between the onset of symptoms and diagnosis
was 5.5–12 months and there has been a trend toward
shortening of that interval to approximately 3 months8.
Although the incidence of myxoma did not change be-
tween the early decade and the latest 10 years, small-
sized and asymptomatic myxomas were more frequently
found during the later decade8. It can be explained by the
development and widespread introduction of echocardio-
graphy. However, as in our patient, many patients with
myxoma experience a significant delay in diagnosis that
can be attributed to the absence or misleading of cardiac
symptoms, or to the presence of extracardiac symptoms
that fail to suggest the proper etiology.
Although it is usually possible to detect intracardiac
tumors with TTE the TEE examination produces spec-
tacular images of a small tumors (1 to 3 mm in diameter),
especially in patients with poor TTE images, and makes
diagnosis, particularly of atrial masses, relatively easy9.
The TEE also permits a clearer picture of the attachment
or stalk of the tumor and more precise characterization
of the size, shape, and location of the mass10. However,
although TEE is a semi-invasive diagnostic technique
with a very low incidence of significant complications,
catastrophic pulmonary embolism during TEE examina-
tion it has been reported11.
In cases in which the echocardiography characteriza-
tion of intracardiac mass is incomplete, cardiac magnetic
resonance imaging (CMR) and multislice spiral com-
puted tomography (MSCT) are particularly helpful in de-
termining the relationship to normal intracardiac struc-
tures and tumor extension to adjacent vascular and
mediastinal structures, infiltration into the pericardium,
influence on cardiac function and surgical planning12,13.
Additionally, superior to echocardiography, CMR and
MSCT could strengthen the diagnostic accuracy by addi-
tional information on tissue characterization using dif-
ferent imaging sequences12,13. These two imaging tech-
niques can differentiate tissue composition, making it
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Fig. 2. The tumor weighted 129 g and measured 98 x 56 x 44 mm
in size.
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possible to identify solid, liquid, hemorrhagic, and fatty,
space-occupying tumors. Typically for cardiac myxomas,
contrast enhancement is moderate and delayed enhance-
ment can be found in the outer circumferential tumor
margins only12.
The accepted treatment of cardiac myxoma is opera-
tive excision14. Surgical removal of a tumor is important
for preventing valvular obstruction, eliminating syste-
mic or pulmonary emboli, maintaining systolic function,
and restoring biventricular diastolic function. Surgical
treatment leads to complete resolution with low rates of
recurrence and good long-term survival14. The overall
risk of recurrence is about 1–3% for sporadic myxoma of-
ten because of inadequate resection1,14. Annual TTE or
TEE review is suggested for a period of 3 to 4 years when
the risk of recurrence is greatest. No chemotherapeutic
or radiotherapeutic approach has been shown to be effec-
tive in preventing the recurrence of myxoma.
In conclusion, the right cardiac myxoma should be
considered in the differential diagnosis of pulmonary em-
bolism, particularly in cases presented in conjunction
with constitutional symptoms and/or hematological dis-
turbances. In these patients echocardiography should be
undertaken early to exclude the rare but treatable dis-
eases of the right heart.
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PLU]NA EMBOLIJA UZROKOVANA MIKSOMOM DESNE PREDKLIJETKE
S A @ E T A K
47-godi{nji mu{karac je hospitaliziran zbog desnostrane pleuriti~ne boli, zaduhe, neproduktivnog ka{lja i blago povi-
{ene tjelesne temperature. EKG-om je potvr|ena sinusna tahikardija sa S1Q3T3 obrascem i nepotpuni blok desne grane,
a scintigrafijom plu}a su pokazani vi{estruki ispadi perfuzije. Po~etna dijagnoza je bila plu}na embolija. Ehokardio-
grafskim pregledom u~injenim prije primjene antikoagulantne terapije, zbog hematolo{kih otklona koji su ukazivali na
mogu}u koagulopatiju (ubrzana sedimentacija eritrocita, leukocitoza, trombocitopenija), potvr|en je veliki, pomi~ni tu-
mor u desnoj predklijetki. Tumor je kirur{ki odstranjen, a histolo{ki nalaz je potvrdio dijagnozu miksoma. U dife-
rencijalnoj dijagnozi plu}ne embolije, osobito ukoliko je pra}ena i konstitucionalnim simptomima i/ili hematolo{kim
otklonima, potrebno je razmatrati i miksom desne predklijetke ili klijetke. U tih je bolesnika potrebno u~initi rani
ehokardiografski pregled kako bi se isklju~ile rijetke ali izlje~ive bolesti desnih {upljina srca.
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